Connor, Clark & Lunn Investment Management (CC&L)
LMAT icon

Connor, Clark & Lunn Investment Management (CC&L)’s LeMaitre Vascular LMAT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,022
Closed -$472K – 1457
2023
Q2 		$472K Buy
+7,022
New +$428K ﹤0.01% 997
2016
Q4 		– Sell
-24,200
Closed -$480K – 939
2016
Q3 		$480K Buy
+24,200
New +$423K ﹤0.01% 588

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s LMAT Position: Q3 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of LeMaitre Vascular (LMAT) in Q3 2023, closing a stake of 7,022 shares — an estimated $472K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LMAT in Q3 2016 and held it in 2 quarters. The position peaked at $480K in Q3 2016. 220 funds tracked by Wall St. Rank hold LMAT as of Q3 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining LeMaitre Vascular position as of Q3 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 7,022 LeMaitre Vascular shares in Q3 2023, an estimated $472K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in LeMaitre Vascular in Q3 2016 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s LeMaitre Vascular position peaked at $480K in Q3 2016.
  • 220 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2023, filed 13 Nov 2023.